These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37220662)
1. Occurrence of Rhabdomyosarcoma After Surgery Combined with oral Sirolimus for Mixed Vascular Malformation of the Tongue. Lin J; Han T; Cui J; Shen W J Craniofac Surg; 2023 Jul-Aug 01; 34(5):e483-e485. PubMed ID: 37220662 [TBL] [Abstract][Full Text] [Related]
2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children]. Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063 [No Abstract] [Full Text] [Related]
5. Is fetal cellular rhabdomyoma an entity or a differentiated rhabdomyosarcoma? A study of patients with rhabdomyoma of the tongue and sarcoma of the tongue enrolled in the intergroup rhabdomyosarcoma studies I, II, and III. Kodet R; Fajstavr J; Kabelka Z; Koutecky J; Eckschlager T; Newton WA Cancer; 1991 Jun; 67(11):2907-13. PubMed ID: 2025857 [TBL] [Abstract][Full Text] [Related]
6. Rhabdomyosarcoma in a pediatric patient: A rare case report. Shrutha SP; Vinit GB Contemp Clin Dent; 2015; 6(1):113-5. PubMed ID: 25684925 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series. Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593 [TBL] [Abstract][Full Text] [Related]
8. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations. Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248 [No Abstract] [Full Text] [Related]
9. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study. Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605 [TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee. Rodeberg DA; Anderson JR; Arndt CA; Ferrer FA; Raney RB; Jenney ME; Brecht IB; Koscielniak E; Carli M; Bisogno G; Oberlin O; Rey A; Ullrich F; Stevens MC; Meyer WH Int J Cancer; 2011 Mar; 128(5):1232-9. PubMed ID: 20473932 [TBL] [Abstract][Full Text] [Related]
11. Effects of physiotherapy combined with sirolimus in a patient with vascular malformation: A case report. Akbayrak T; Orhan C; Baran E; Kaya S; Coskun G; Varan A Turk J Pediatr; 2016; 58(2):203-207. PubMed ID: 27976563 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin targeting mTOR and hedgehog signaling pathways blocks human rhabdomyosarcoma growth in xenograft murine model. Kaylani SZ; Xu J; Srivastava RK; Kopelovich L; Pressey JG; Athar M Biochem Biophys Res Commun; 2013 Jun; 435(4):557-61. PubMed ID: 23665330 [TBL] [Abstract][Full Text] [Related]
13. Successful Treatment of a Complex Vascular Malformation With Sirolimus and Surgical Resection. Goldenberg DC; Carvas M; Adams D; Giannotti M; Gemperli R J Pediatr Hematol Oncol; 2017 May; 39(4):e191-e195. PubMed ID: 27820120 [TBL] [Abstract][Full Text] [Related]
14. Sirolimus for the treatment of children with various complicated vascular anomalies. Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705 [TBL] [Abstract][Full Text] [Related]
15. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee. Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515 [TBL] [Abstract][Full Text] [Related]
16. [Rhabdomyosarcoma in the area of the head-neck. A synopsis of some cases, therapeutic possibilities and prognoses]. Hess A; Schröder U; Schröder R; Michel O Laryngorhinootologie; 1998 Oct; 77(10):557-63. PubMed ID: 9842519 [TBL] [Abstract][Full Text] [Related]
17. An unusually large spindle cell sarcoma of the tongue in a male child. Abdulai AE; Nuamah IK; Avogo D; Gyasi RK; Renner LA Ghana Med J; 2013 Dec; 47(4):208-10. PubMed ID: 24669028 [TBL] [Abstract][Full Text] [Related]
18. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study. Kodet R; Newton WA; Hamoudi AB; Asmar L; Jacobs DL; Maurer HM Am J Surg Pathol; 1993 May; 17(5):443-53. PubMed ID: 8470759 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of sirolimus in children with lymphatic malformations of the head and neck. Wiegand S; Dietz A; Wichmann G Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3801-3810. PubMed ID: 35526176 [TBL] [Abstract][Full Text] [Related]
20. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group. Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W; Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]